A Very Different Look at COVID-19
InspectIR is the only testing methodology that does not create cross reactivity, which leads to pre-analytical error, based on adding a solvent or another reagent to bind to a specimen for analysis.
There is also no storage of any biologic material in the InspectIR test.
What makes us different:
Chemical-lab-in-a-box: we are analyzing breath via mass spectrometry.
InspectIR is the first company to make a commercially available miniature mass spectrometer to analyze breath samples directly
Leveraging Proven Science to Monitor Health & Wellness in a COVID-19 World
The COVID-19 pandemic has thrown our world into a state of unknown. Like many, InspectIR Systems asked “how can we help?” and began the necessary research. The results have been outstanding.
InspectIR Systems, LLC has begun clinical trials, detecting the coronavirus in the breath of subjects. As we push towards FDA approval and product launch, the future is exciting.
Detection is an Essential Step on the Path to Enforcement & Control
With an increased awareness of the opioid epidemic combined with the legal spread of medical and recreational cannabis; the ability to accurately test individuals via a mobile, portable, or roadside device is not currently available.
InspectIR Systems, LLC (IR) is a research, development and device company focused on non-invasive portable detection tools to identify recent opioid and/or cannabis usage.
The Numbers Never Lie
Statistics nationwide are telling a story of immediate need for an accurate “real-time” detection device. The Inspect IR device will be the first of its kind.
States with Legalization of Medical & Recreational Cannabis
Deaths Daily from Opioid-Related Overdoses
2016 Opioid Overdose Deaths
Viable Non-Invasive Detection Tools Available Today
Contact InspectIR Systems, LLC
InspectIR is in rapid growth mode. Interested in learning more? Complete the form below & a member of our team will be in touch shortly,